EU-SAFETY_HEALTH_WORK-PREAMBLE
EU-SAFETY_HEALTH_WORK-PREAMBLE
Safety and Health of Workers at Work Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)
This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.
RELEVANT LEGISLATION
Last updated 07 listopada 2024. Database contains 4691 unique substances/entries.
Filter the list
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
Acute Tox. 3; STOT RE 2 |
||
|
show/hide
|
-
|
-
|
Acute Tox. 2; Acute Tox. 1; STOT RE 2 |
|
|
-
|
-
|
Carc. 1B; Skin Sens. 1 |
||
|
-
|
-
|
F Fungi |
||
|
-
|
-
|
P Parasites |
||
|
-
|
-
|
P Parasites |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
F Fungi |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
Substance identity is confidential or pending assessment. If possible, following assessment the proper substance identifiers will be displayed.
|
-
|
-
|
Repr. 2; STOT RE 2 |
|
|
Substance identity is confidential or pending assessment. If possible, following assessment the proper substance identifiers will be displayed.
|
-
|
-
|
Carc. 2; Repr. 1B; Lact.; Acute Tox. 4; STOT RE 1; Eye Dam. 1 |
|
|
Substance identity is confidential or pending assessment. If possible, following assessment the proper substance identifiers will be displayed.
|
-
|
-
|
Ox. Sol. 2; Repr. 1B; Acute Tox. 4; STOT SE 3; Eye Dam. 1 |
|
|
Substance identity is confidential or pending assessment. If possible, following assessment the proper substance identifiers will be displayed.
|
-
|
-
|
Ox. Sol. 2; Repr. 1B; Acute Tox. 3; Acute Tox. 4; STOT SE 3; Eye Dam. 1 |
|
|
-
|
-
|
Acute Tox. 3; Acute Tox. 4; Eye Irrit. 2 |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
68583-16-4
|
B Bacteria and similar species |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
572-48-5
|
Acute Tox. 3 |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
B Bacteria and similar species |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
F Fungi |
||
|
-
|
-
|
F Fungi |
||
|
-
|
-
|
P Parasites |
||
|
-
|
-
|
P Parasites |
||
|
-
|
-
|
P Parasites |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
1563-67-3
|
Acute Tox. 3 |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||
|
-
|
-
|
Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1 |
||
|
-
|
74195-78-1
|
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
||
|
-
|
63919-26-6
|
Acute Tox. 4 |
||
|
-
|
-
|
P Parasites |
||
|
-
|
19372-20-4
|
Carc. 1A; STOT RE 1; Resp. Sens. 1; Skin Sens. 1 |
||
|
-
|
-
|
P Parasites |
||
|
-
|
83-59-0
|
Acute Tox. 3; Acute Tox. 4 |
||
|
-
|
-
|
P Parasites |
||
|
-
|
-
|
Carc. 1B |
||
|
-
|
-
|
V Viruses: Member States are to ensure that all viruses which have already been isolated in humains and which have not been assessed and allocated in this Annex are classified in group 2 as a minimum, except where Member States have proof that they are unlikely to cause disease in humans. |
||